0001209191-23-060007.txt : 20231229 0001209191-23-060007.hdr.sgml : 20231229 20231229163348 ACCESSION NUMBER: 0001209191-23-060007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231228 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elam Nevan C CENTRAL INDEX KEY: 0001314773 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 231528140 MAIL ADDRESS: STREET 1: C/O NEKTAR THERAPEUTICS STREET 2: 150 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 51285113796 MAIL ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-28 0 0001160308 Savara Inc SVRA 0001314773 Elam Nevan C ONE SUMMIT SQUARE, 1717 LANGHORNE NEWTOWN ROAD, SUITE 300 LANGHORNE PA 19047 1 0 0 0 0 Common Stock 2023-12-28 4 M 0 1758 0.82 A 64343 D Common Stock 2023-12-28 4 M 0 12000 1.59 A 76343 D Common Stock 2023-12-28 4 M 0 40000 1.23 A 116343 D Common Stock 2023-12-28 4 S 0 93843 4.7131 D 22500 D Stock Option (Right to Buy) 0.82 2023-12-28 4 M 0 1758 0.00 D 2024-07-24 Common Stock 1758 0 D Stock Option (Right to Buy) 1.59 2023-12-28 4 M 0 12000 0.00 D 2029-12-20 Common Stock 12000 0 D Stock Option (Right to Buy) 1.23 2023-12-28 4 M 0 40000 0.00 D 2030-12-16 Common Stock 40000 0 D The price is a weighted average sales price. The sale prices ranged from $4.70 to $4.795. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014. The shares subject to the option vested and became exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019. The shares subject to the option vested and became exercisable on December 16, 2021. /s/ David Lowrance, as attorney-in-fact for Nevan Elam 2023-12-29